Recall
FDAHealthAugust 24, 2024

Rubicon Research Private Limited — AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limi

⚠️ Discoloration

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
August 24, 2024

Nationwide in the US

What's affected?

Product
AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01
UPC
0372888047010
Lot code
30575HF1

Additional details

Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01

What should I do?

Recommended action

Class III recall. Voluntary: Firm initiated Quantity affected: 3,984 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.